Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
about
Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer's and Parkinson's DiseaseMitochondria: A Therapeutic Target for Parkinson's Disease?A Review of Recent Advances in Neuroprotective Potential of 3-N-Butylphthalide and Its DerivativesA chemical screen to identify inducers of the mitochondrial unfolded protein response in C. elegans.Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases.Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia.Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders.Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms.Dl-3n-butylphthalide reduces epileptiform activity through GluA2-lacking calcium-permeable AMPARs in epilepsy models.DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure.Alpha Lipoamide Ameliorates Motor Deficits and Mitochondrial Dynamics in the Parkinson's Disease Model Induced by 6-Hydroxydopamine.Tanshinone I Induces Mitochondrial Protection through an Nrf2-Dependent Mechanism in Paraquat-TreatedHuman Neuroblastoma SH-SY5Y Cells.Sophora flavescens Aiton Decreases MPP+-Induced Mitochondrial Dysfunction in SH-SY5Y Cells.Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing.Inhibitory Effect of Astaxanthin on Oxidative Stress-Induced Mitochondrial Dysfunction-A Mini-Review
P2860
Q26738450-0BA5222F-1C28-4411-8964-761CD0A957E6Q26784216-99C5C833-EB84-482D-BBDB-19CB32D11136Q34548561-C41A0BB9-07B8-4CCB-AD70-A1D47136F351Q36001549-C15F370E-8D58-479D-96BE-D72D07AEAB21Q37106933-93151A9C-3F75-422A-B0F7-40563D2910F7Q37592662-FF1E10A3-D1A4-44A3-A13A-5C8EAC6F3F7AQ38742951-B4E3F907-ADBF-4690-99B0-53FAF6A3987EQ38743021-9EB11D9A-F821-4BA8-987A-DDA439DC7F77Q38790569-DE961478-C2AC-47DF-B433-8EEC54857447Q39132336-8C360AA5-1249-43F4-AEC3-7F5758252B1BQ47104829-8B25C57D-84B2-410D-88F1-E75CC969B836Q47242186-A4765104-B59A-4167-934F-F448F1058A08Q47581099-E4374E72-5C56-4911-84E1-32913714AA2CQ53004544-7772D071-9C94-4322-9ED6-96B2359E76F6Q54979512-FB999941-37D1-42E7-B2A6-B6ABB528463BQ55360734-E6F34B3F-1742-4595-9CB9-CA14B739E06DQ58725358-C6DABD61-B25D-4FD8-8A22-C76A7DDB6CEE
P2860
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
@ast
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
@en
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
@nl
type
label
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
@ast
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
@en
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
@nl
prefLabel
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
@ast
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
@en
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
@en
P2093
Carlos Fernández-Moriano
Elena González-Burgos
M. Pilar Gómez-Serranillos
P2860
P304
P3181
P356
10.1155/2015/408927
P407
P5008
P577
2015-01-01T00:00:00Z
2015-04-29T00:00:00Z